Neostigmine Methylsulfate
NDC 65145-112, Neostigmine Methylsulfate, injection, from Caplin Steriles Limited.
- Product NDC
- 65145-112
- Status
- Listed
- Labeler
- Caplin Steriles Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213074
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65145-112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65145-112-10 | 65145011210 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-112-10) / 10 mL in 1 VIAL, MULTI-DOSE (65145-112-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/11f38ea2-be55-4119-8eee-776f84c5e7f8
Use it
Look up 65145-112 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65145-112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65145-112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.